HIV prevention pill found to help men, not women
Bottles of antiretroviral drug Truvada are displayed at Jack's Pharmacy on November 23, 2010 in San Anselmo, California. / Justin Sullivan/Getty Images
Researchers are stopping a study testing a daily pill to prevent infection with the AIDS virus in thousands of African women.
Partial results show that women taking Truvada, made by Gilead Sciences Inc., are just as likely to get HIV as other women who take dummy pills.
Even if the study continues, it will not be able to determine whether the pills do any good. The results are a disappointment because a study last fall found that Truvada did help prevent infections in gay and bisexual men, and many AIDS experts view it as a breakthrough.
The new study's results were announced on Monday.
In the earlier study on Truvada, researchers found that the drug cut new HIV infections by 44 percent among gay and bisexual men, reports WebMD.
The study of the effects of Truvada on men began in 2007 in Brazil, Ecuador, Peru, South Africa, Thailand, and the U.S.
The Wall Street Journal reports that Truvada had U.S. sales of $1.3 billion last year.
Popular in Health
- Health risks remain for Okla. tornado responders, victims
- Bed sharing may increase risk of SIDS by five times
- Disney pulls show that makes fun of gluten-free child
- "Clouds" singer known for viral hit dies from osteosarcoma
- Miami face-chewing victim still recovering one year later
- Environmental Working Group's top sunscreens for 2013 12 Photos
- Skin cancer self-exam: What to look for (PHOTOS)
- Which sunscreens are recommended for 2013?